Global and China Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

Home/Global and China Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

Global and China Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

Healthcare, Pharma & Healthcare

Publication ID:

QYR11201664

Publication Date:

November 23, 2020

Pages:

Publisher:

QYR

Region:

Global

$3,900.00

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

Global Alzheimer's Disease Therapeutics and Diagnostics Scope and Market Size
Alzheimer's Disease Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Biomarkers
Cholinesterase inhibitors
NMDA receptor antagonists
Brain imaging
Blood tests

Market segment by Application, split into
Drugs Market
Diagnostics Market

Based on regional and country-level analysis, the Alzheimer's Disease Therapeutics and Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Alzheimer's Disease Therapeutics and Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Biomarkers
1.2.3 Cholinesterase inhibitors
1.2.4 NMDA receptor antagonists
1.2.5 Brain imaging
1.2.6 Blood tests
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Drugs Market
1.3.3 Diagnostics Market
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Perspective (2015-2026)
2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Growth Trends by Regions
2.2.1 Alzheimer's Disease Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alzheimer's Disease Therapeutics and Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Market Size
3.1.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alzheimer's Disease Therapeutics and Diagnostics Revenue
3.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2019
3.5 Key Players Alzheimer's Disease Therapeutics and Diagnostics Area Served
3.6 Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Alzheimer's Disease Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2021-2026)

5 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2026)
6.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
6.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
6.4 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2026)
7.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
7.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2026)
8.2 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
8.3 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
8.4 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2026)
9.2 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
9.3 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
9.4 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Namenda
11.1.1 Namenda Company Details
11.1.2 Namenda Business Overview
11.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.1.4 Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020))
11.1.5 Namenda Recent Development
11.2 Aricept
11.2.1 Aricept Company Details
11.2.2 Aricept Business Overview
11.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.2.4 Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.2.5 Aricept Recent Development
11.3 Exelon
11.3.1 Exelon Company Details
11.3.2 Exelon Business Overview
11.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.3.4 Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.3.5 Exelon Recent Development
11.4 Solanezumab
11.4.1 Solanezumab Company Details
11.4.2 Solanezumab Business Overview
11.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.4.4 Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.4.5 Solanezumab Recent Development
11.5 Gantenerumab
11.5.1 Gantenerumab Company Details
11.5.2 Gantenerumab Business Overview
11.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.5.4 Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.5.5 Gantenerumab Recent Development
11.6 Verubecestat
11.6.1 Verubecestat Company Details
11.6.2 Verubecestat Business Overview
11.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.6.4 Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.6.5 Verubecestat Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.7.4 Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.7.5 Pfizer Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.8.4 Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.8.5 Eisai Recent Development
11.9 Actavis
11.9.1 Actavis Company Details
11.9.2 Actavis Business Overview
11.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.9.4 Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.9.5 Actavis Recent Development
11.10 Lundbeck
11.10.1 Lundbeck Company Details
11.10.2 Lundbeck Business Overview
11.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Introduction
11.10.4 Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
11.10.5 Lundbeck Recent Development
11.11 Daiichi Sankyo
10.11.1 Daiichi Sankyo Company Details
10.11.2 Daiichi Sankyo Business Overview
10.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Introduction
10.11.4 Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
10.11.5 Daiichi Sankyo Recent Development
11.12 Novartis
10.12.1 Novartis Company Details
10.12.2 Novartis Business Overview
10.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Introduction
10.12.4 Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
10.12.5 Novartis Recent Development
11.13 TauRx
10.13.1 TauRx Company Details
10.13.2 TauRx Business Overview
10.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Introduction
10.13.4 TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
10.13.5 TauRx Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Tables and Figures

List of Tables
Table 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Biomarkers
Table 4. Key Players of Cholinesterase inhibitors
Table 5. Key Players of NMDA receptor antagonists
Table 6. Key Players of Brain imaging
Table 7. Key Players of Blood tests
Table 8. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Regions (2015-2020)
Table 12. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Regions (2021-2026)
Table 14. Alzheimer's Disease Therapeutics and Diagnostics Market Market Trends
Table 15. Alzheimer's Disease Therapeutics and Diagnostics Market Drivers
Table 16. Alzheimer's Disease Therapeutics and Diagnostics Market Challenges
Table 17. Alzheimer's Disease Therapeutics and Diagnostics Market Restraints
Table 18. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2019)
Table 21. Global Alzheimer's Disease Therapeutics and Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Type (2015-2020)
Table 27. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2021-2026)
Table 28. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Application (2015-2020)
Table 29. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Application (2021-2026)
Table 31. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 33. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 35. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2015-2020)
Table 37. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 39. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 41. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2015-2020)
Table 43. China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 44. China Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 45. China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 46. China Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 47. China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 48. China Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2015-2020)
Table 49. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 51. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 53. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2015-2020)
Table 55. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2015-2020)
Table 57. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2015-2020)
Table 59. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2015-2020)
Table 61. Namenda Company Details
Table 62. Namenda Business Overview
Table 63. Namenda Product
Table 64. Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 65. Namenda Recent Development
Table 66. Aricept Company Details
Table 67. Aricept Business Overview
Table 68. Aricept Product
Table 69. Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 70. Aricept Recent Development
Table 71. Exelon Company Details
Table 72. Exelon Business Overview
Table 73. Exelon Product
Table 74. Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 75. Exelon Recent Development
Table 76. Solanezumab Company Details
Table 77. Solanezumab Business Overview
Table 78. Solanezumab Product
Table 79. Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 80. Solanezumab Recent Development
Table 81. Gantenerumab Company Details
Table 82. Gantenerumab Business Overview
Table 83. Gantenerumab Product
Table 84. Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 85. Gantenerumab Recent Development
Table 86. Verubecestat Company Details
Table 87. Verubecestat Business Overview
Table 88. Verubecestat Product
Table 89. Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 90. Verubecestat Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Eisai Business Overview
Table 97. Eisai Product
Table 98. Eisai Company Details
Table 99. Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 100. Eisai Recent Development
Table 101. Actavis Company Details
Table 102. Actavis Business Overview
Table 103. Actavis Product
Table 104. Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 105. Actavis Recent Development
Table 106. Lundbeck Company Details
Table 107. Lundbeck Business Overview
Table 108. Lundbeck Product
Table 109. Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 110. Lundbeck Recent Development
Table 111. Daiichi Sankyo Company Details
Table 112. Daiichi Sankyo Business Overview
Table 113. Daiichi Sankyo Product
Table 114. Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 115. Daiichi Sankyo Recent Development
Table 116. Novartis Company Details
Table 117. Novartis Business Overview
Table 118. Novartis Product
Table 119. Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 120. Novartis Recent Development
Table 121. TauRx Company Details
Table 122. TauRx Business Overview
Table 123. TauRx Product
Table 124. TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020) (US$ Million)
Table 125. TauRx Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Biomarkers Features
Figure 3. Cholinesterase inhibitors Features
Figure 4. NMDA receptor antagonists Features
Figure 5. Brain imaging Features
Figure 6. Blood tests Features
Figure 7. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
Figure 8. Drugs Market Case Studies
Figure 9. Diagnostics Market Case Studies
Figure 10. Alzheimer's Disease Therapeutics and Diagnostics Report Years Considered
Figure 11. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Regions (2021-2026)
Figure 14. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Players in 2019
Figure 15. Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2019
Figure 17. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Namenda Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 45. Aricept Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 46. Exelon Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 47. Solanezumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 48. Gantenerumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 49. Verubecestat Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 50. Pfizer Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 51. Eisai Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 52. Actavis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 53. Lundbeck Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 54. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 55. Novartis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 56. TauRx Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Companies Covered

Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?

If yes, then please use the form given below and we will get in touch with you immediately.

Kindly use your official email address and contact number to ensure speedy response.

Name *

Email *

Company

Contact Number *

Report Title *

Your Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Drag or click the correct shape to the grey "drop area".